New · CUSIP 00773J202 · who reports it, how much, and how much it matters to them
43 of the 720 hedge fund managers we track reported shares of Spyre Therapeutics, Inc. (Nasdaq: SYRE) on Form 13F for 30 June 2026. Between them they reported USD 1.4bn. The largest position belongs to Perceptive Advisors, at USD 383m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Perceptive Advisors6 funds on PPLI.com | USD 383m | 5.8% |
| 2 | RTW Investments2 funds on PPLI.com | USD 377m | 3.2% |
| 3 | Adage Capital Management1 fund on PPLI.com | USD 153m | 0.2% |
| 4 | Holocene Advisors2 funds on PPLI.com | USD 90m | 0.2% |
| 5 | Marshall Wace LLP84 funds on PPLI.com | USD 88m | 0.1% |
| 6 | Polar Capital LLP26 funds on PPLI.com | USD 88m | 0.2% |
| 7 | Braidwell12 funds on PPLI.com | USD 78m | 2.9% |
| 8 | Samlyn Capital8 funds on PPLI.com | USD 36m | 0.6% |
| 9 | Cormorant Asset Management1 fund on PPLI.com | USD 20m | 1.0% |
| 10 | Millennium Management6 funds on PPLI.com | USD 17m | 0.0% |
| 11 | Orbimed Advisors1 fund on PPLI.com | USD 17m | 0.3% |
| 12 | Balyasny Asset Management25 funds on PPLI.com | USD 13m | 0.0% |
| 13 | Squarepoint Ops7 funds on PPLI.com | USD 12m | 0.0% |
| 14 | Armistice Capital1 fund on PPLI.com | USD 12m | 0.1% |
| 15 | Citadel Advisors32 funds on PPLI.com | USD 9.2m | 0.0% |
| 16 | Boxer Capital Management1 fund on PPLI.com | USD 8.9m | 0.7% |
| 17 | HighVista Strategies27 funds on PPLI.com | USD 6.9m | 1.6% |
| 18 | Hudson Bay Capital Management8 funds on PPLI.com | USD 5.2m | 0.0% |
| 19 | Cinctive Capital Management5 funds on PPLI.com | USD 4.3m | 0.2% |
| 20 | PFM Health Sciences3 funds on PPLI.com | USD 4.1m | 0.4% |
| 21 | Rock Springs Capital Management2 funds on PPLI.com | USD 3.8m | 0.2% |
| 22 | Engineers Gate Manager1 fund on PPLI.com | USD 3.4m | 0.0% |
| 23 | D. E. Shaw & Co.15 funds on PPLI.com | USD 2.3m | 0.0% |
| 24 | Aquatic Capital Management3 funds on PPLI.com | USD 2.2m | 0.1% |
| 25 | Freestone Grove Partners1 fund on PPLI.com | USD 2m | 0.0% |
| 26 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.7m | 0.0% |
| 27 | Neo Ivy Capital Management1 fund on PPLI.com | USD 1.3m | 0.3% |
| 28 | Two Sigma Investments35 funds on PPLI.com | USD 1.1m | 0.0% |
| 29 | Atom Investors1 fund on PPLI.com | USD 1.1m | 0.1% |
| 30 | Global Endowment Management90 funds on PPLI.com | USD 1.1m | 0.1% |
| 31 | Diametric Capital2 funds on PPLI.com | USD 888,000 | 0.1% |
| 32 | Persistent Asset Partners10 funds on PPLI.com | USD 778,000 | 0.2% |
| 33 | Brevan Howard Capital Management39 funds on PPLI.com | USD 736,000 | 0.0% |
| 34 | Boothbay Fund Management2 funds on PPLI.com | USD 573,000 | 0.0% |
| 35 | Dark Forest Capital Management2 funds on PPLI.com | USD 461,000 | 0.0% |
| 36 | Wexford Capital8 funds on PPLI.com | USD 355,000 | 0.0% |
| 37 | Artia Global Partners1 fund on PPLI.com | USD 355,000 | 0.1% |
| 38 | Landscape Capital Management4 funds on PPLI.com | USD 344,000 | 0.0% |
| 39 | Tudor Investment Corporation10 funds on PPLI.com | USD 235,000 | 0.0% |
| 40 | CIBC Asset Management69 funds on PPLI.com | USD 216,000 | 0.0% |
| 41 | Bayforest Capital1 fund on PPLI.com | USD 205,000 | 0.2% |
| 42 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 191,000 | 0.0% |
| 43 | The Quarry1 fund on PPLI.com | USD 178 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Perceptive Advisors | USD 383m | 5.8% |
| 2 | RTW Investments | USD 377m | 3.2% |
| 3 | Braidwell | USD 78m | 2.9% |
| 4 | HighVista Strategies | USD 6.9m | 1.6% |
| 5 | Cormorant Asset Management | USD 20m | 1.0% |
| 6 | Boxer Capital Management | USD 8.9m | 0.7% |
| 7 | Samlyn Capital | USD 36m | 0.6% |
| 8 | PFM Health Sciences | USD 4.1m | 0.4% |
| 9 | Orbimed Advisors | USD 17m | 0.3% |
| 10 | Neo Ivy Capital Management | USD 1.3m | 0.3% |
Spyre Therapeutics, Inc. trades under the symbol SYRE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 00773J202.
43 of the 720 hedge fund managers PPLI.com tracks reported Spyre Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 383m), RTW Investments (USD 377m), Adage Capital Management (USD 153m), Holocene Advisors (USD 90m) and Marshall Wace LLP (USD 88m).
43 managers in our coverage reported it, and between them they run 593 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Perceptive Advisors, where the position was 5.8% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Spyre Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.